arrow
N

Nunghathai Sawasdee

Mahidol University
H指数:21
被引数:1,162

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fourth-generation chimeric antigen receptor T cells targeting mucin 1 for enhanced anti-tumor activity against breast cancer

第四代嵌合抗原受体T细胞靶向粘蛋白1以增强对乳腺癌的抗肿瘤活性

2026-09-180
OAAI
Intravitreal GD2-Specific Chimeric Antigen Receptor T-Cell Therapy for Refractory Retinoblastoma

玻璃体内GD2特异性嵌合抗原受体T细胞疗法治疗难治性视网膜母细胞瘤

2026-07-010
OAAI
CD138-targeted bispecific protein engager-armed T cells exhibit potent and selective cytotoxicity against multiple myeloma cells

CD138靶向双特异性蛋白连接器武装T细胞对多发性骨髓瘤细胞表现出强效且特异的选择性细胞毒性

2026-02-130
OAAI
Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells ( vol 12 , 6154 , 2022)
2025-02-060
OAAI
Enhanced antitumor efficacy, proliferative capacity, and alleviation of T cell exhaustion by fifth-generation chimeric antigen receptor T cells targeting B cell maturation antigen in multiple myeloma

多发性骨髓瘤中靶向b细胞成熟抗原的第五代嵌合抗原受体T细胞增强的抗肿瘤功效,增殖能力和减轻T细胞耗竭

2023-12-015
OAAI
Anti-CD19 chimeric antigen receptor T cells secreting anti-PD-L1 single-chain variable fragment attenuate PD-L1 mediated T cell inhibition

分泌anti-PD-L1单链可变片段的Anti-CD19嵌合抗原受体T细胞减弱PD-L1介导的T细胞抑制

2022-12-018
OAAI
Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells
2022-04-1322
OAAI